Cantitate/Preț
Produs

Analysis of Safety Data of Drug Trials: An Update

Autor Ton J. Cleophas, Aeilko H. Zwinderman
en Limba Engleză Hardback – 8 mar 2019
In 2010, the 5th edition of the textbook, "Statistics Applied to Clinical Studies", was published by Springer and since then has been widely distributed. The primary object of clinical trials of new drugs is to demonstrate efficacy rather than safety. However, a trial in humans which does not adequately address safety is unethical, while the assessment of safety variables is an important element of the trial. An effective approach is to present summaries of the prevalence of adverse effects and their 95% confidence intervals. In order to estimate the probability that the differences between treatment and control group occurred merely by chance, a statistical test can be performed. In the past few years, this pretty crude method has been supplemented and sometimes, replaced with more sophisticated and better sensitive methodologies, based on machine learning clusters and networks, and multivariate analyses. As a result, it is time that an updated version of safety data analysis was published.
The issue of dependency also needs to be addressed. Adverse effects may be either dependent or independent of the main outcome. For example, an adverse effect of alpha blockers is dizziness and this occurs independently of the main outcome "alleviation of Raynaud 's phenomenon". In contrast, the adverse effect "increased calorie intake" occurs with "increased exercise", and this adverse effect is very dependent on the main outcome "weight loss". Random heterogeneities, outliers, confounders, interaction factors are common in clinical trials, and all of them can be considered as kinds of adverse effects of the dependent type. Random regressions and analyses of variance, high dimensional clusterings, partial correlations, structural equations models, Bayesian methods are helpful for their analysis. 
The current edition was written for non-mathematicians, particularly medical and health professionals and students. It provides examples of modern analytic methods so far largely unused in safety analysis. All of the 14 chapters have two core characteristics, First, they are intended for current usage, and they are particularly concerned with that usage. Second, they try and tell what readers need to know in order to understand and apply the methods. For that purpose, step by step analyses of both hypothesized and real data examples are provided. 
Citește tot Restrânge

Preț: 70851 lei

Preț vechi: 74579 lei
-5% Nou

Puncte Express: 1063

Preț estimativ în valută:
13559 14085$ 11263£

Carte disponibilă

Livrare economică 13-27 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783030058036
ISBN-10: 3030058034
Pagini: 185
Ilustrații: XI, 217 p. 191 illus., 28 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.6 kg
Ediția:1st ed. 2019
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland

Cuprins

Preface.- General Introduction.- Significant and Insignificant Adverse Effect.- Incidence Ratios and Reporting Ratios of Adverse Effects.- Safety Analysis and the Alternative Hypothesis.- Forest Plots of Adverse Effects.- Graphics of Adverse Effects .- Repeated Measures Methods for Testing Adverse Effects .- Benefit Risk Ratios.- Equivalence, Non-inferiority and Superiority Testing of Adverse Effects.- Part II The Analysis of Dependent Adverse Effects.- Independent and Dependent Adverse Effects. Categorical Predictors Assessed as Dependent Adverse Effects. Adverse Effect of the Dependent Type in Crossover Trial.- Confoundings and Interactions Assessed as Dependent Adverse Effects.- Subgroup Characteristics Assessed as Dependent Adverse Effects.- Random Effects Assessed as Dependent Adverse Effects.- Outliers Assessed as Dependent Adverse Effects.- Index. 

Recenzii

“The analysis of safety data in drug trials, or in other drug studies, is an important topic. … it is doubtful that this would make it a real book about safety analysis.” (ISCB News, Vol. 68, 2019)

Notă biografică

The authors are well-qualified in their field. Professor Zwinderman is past-president of the International Society of Biostatistics (2012-2015), and Professor Cleophas is past-president of the American College of Angiology (2000-2002). 

Professor Zwinderman is one of the Principle Investigators of the Academic Medical Center Amsterdam, and his research is concerned with developing statistical methods for new research designs in biomedical science, particularly integrating omics data, like genomics, proteomics, metabolomics, and analysis tools based on parallel computing and the use of cluster computers and grid computing.   

Professor Cleophas is a member of the Academic Committee of the European College of Pharmaceutical Medicine, that provides, on behalf of 22 European Universities, the Master-ship trainings  "Pharmaceutical Medicine" and "Medicines Development".  

From their expertise theyshould be able to make adequate selections of modern methods for clinical data analysis for the benefit of physicians, students, and investigators. The authors have been working and publishing together for 18 years, and their research can be characterized as a continued effort to demonstrate that clinical data analysis is not mathematics but rather a discipline at the interface of biology and mathematics.

The authors as professors and teachers in statistics at universities in The Netherlands and France for the most part of their lives, are concerned, that their students find regression-analyses harder than any other methodology in statistics. This is serious, because almost all of the novel methodologies in current data mining and data analysis include elements of regression-analysis, and they do hope that the current production "Regression Analysis for Starters and 2nd Levelers" will be a helpful companion for the purpose.
 
Five textbookscomplementary to the current production and written by the same authors are 

Statistics applied to clinical studies 5th edition, 2012, 
Machine learning in medicine a complete overview, 2015, 
SPSS for starters and 2nd levelers 2nd edition, 2015, 
Clinical data analysis on a pocket calculator 2nd edition, 2016, 
Modern Meta-analysis, 2017
Regression Analysis in Medical Research, 2018 
all of them published by Springer 


Textul de pe ultima copertă

The authors, as professors in statistics at various universities in Europe, are worrried about the poor quality of safety data analysis of clinical trials, despite its importance in drug development and pharmacovigilance. Clinical trials, not adequately addressing safety, are unethical. An effective approach for the purpose is to present summaries of prevalences. In order to estimate the probability, that the differences between treatment and control group did not occur merely by chance, a statistical test can be performed. This pretty crude method has recently be supplemented with better sensitive methodologies, based on machine learning clusters and networks, and multivariate analyses.

Another important novelty with safety data analysis is the new insights into hypothesis testing, favoring the alternative hypotheses instead of the null hypotheses.
Finally the issue of dependency is addressed. Adverse effects may be either dependent or independent of the main outcome. Dependent adverse effect are dependent not only on the treatment modalities, but also on the outcome of the trials. Random heterogeneities, outliers, confounders, interaction factors are common in clinical trials, and all of them can be considered kinds of adverse effects of the dependent type. Random regressions and analyses of variance, high dimensional clusterings, partial correlations, structural equations models, and other Bayesian methods are helpful for their analysis. 

The current edition was particularly written for medical and health professionals and students. It provides examples of modern analytic methods so far largely unused. All of the 16 chapters have two core characteristics, first they are for current usage, second they try and tell what readers need to know in order to understand the methods. Step by step analyses are given and self-assessment examples are supplied. Each chapter can be studied as a stand-alone.


Caracteristici

Provides novel and better sensitive methodologies for assessing and testing adverse effects based on machine learning clusters and networks, and multivariate analyses Another important novelty with safety data analysis is new insights into hypothesis testing, favoring the alternative hypotheses over the null hypotheses The authors give a systematic presentation of so far poorly recognized dependent adverse effects, and give special methods for detecting and managing them